# Chengdu Shengnuo Biopharm Co Ltd – FDA Inspection, Sep 8, 2023

Source: https://www.keypedia.com/records/fda_inspections/chengdu-shengnuo-biopharm-co-ltd/9c07302f-5743-4fd1-8da4-72f5e26f2e72
Source feed: FDA_Inspections

> FDA inspection 1219460 of Chengdu Shengnuo Biopharm Co Ltd, September 08, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219460
- Company Name: Chengdu Shengnuo Biopharm Co Ltd
- Inspection Date: 2023-09-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1334998 - 2026-08-27](https://www.keypedia.com/records/fda_inspections/chengdu-shengnuo-biopharm-co-ltd/8579538b-d6b3-4b81-b520-51c8447f010d)
- FDA Inspection 978495 - 2016-06-10
- FDA Inspection 924616 - 2015-04-09
- FDA Inspection 784098 - 2012-05-24

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/djamila-harouaka/106cef03-a214-4184-963a-6580d3bd7fd9)

Company: https://www.keypedia.com/companies/chengdu-shengnuo-biopharm-co-ltd/7e22dc83-be1b-41e1-af8c-856dd7a35375

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
